Synovus price target lowered to $60 from $66 at Barclays

Barclays analyst Jared Shaw lowered the firm’s price target on Synovus (SNV) to $60 from $66 and keeps an Overweight rating on the shares as part of a Q1 preview for the mid-cap banks. Heightened uncertainty hurts 2025 outlooks and could lead to lowered guidance at earnings, but buyback activity is a potential catalyst for some, the analyst tells investors in a research note.